Lacerta Bio is a business development consultancy specializing in identifying, assessing, negotiating, and closing licensing and partnership opportunities for the pharmaceutical, biotechnology, and drug delivery industries.

We also work with and support internal business development teams with market research, competitive intelligence, financial modeling, and other support services.

If you need assistance finding or assessing business development and/or partnership opportunities, contact us at info@lacertabio.com.


Current Projects

Seeking Parenteral & Ophthalmic Products for In-Licensing  
Posted on Jan 21, 2016

Article

Lacerta Bio is seeking both parenteral and ophthalmic (topical) products for in-licensing on behalf of a US-based client.  Key criteria are: > Products which can be developed via the 505(b)(2) regulatory process in the US > No specific therapeutic area or indication > Injectable could be infusion, prefilled syringe, or related presentation > Ophthalmics are

  Read More»

Novel Anti-Bacterials Available For Licensing  
Posted on Oct 04, 2016

Article

  Lacerta Bio is pleased to present two novel antibiotics with excellent properties on behalf of our client. The first is a peptide antibiotic which inhibits cell wall synthesis, making it suitable for the intravenous treatment of troublesome Gram Positive bacteria, such as MRSA, VRE, and many other resistant pathogens. The second is a liposlycodepsipeptide suitable

  Read More»

Novel Clinical-Stage Pain Candidates Available for Licensing  
Posted on Jul 11, 2017

Article

  Our European client has developed a series of novel, patented salt forms of the most popular NSAIDS on the market (ibuprofen, naproxen, etc.). Clinical data demonstrates three important properties of these new compounds: Enhanced Safety – In multiple clinical studies, our client has shown that these novel salt forms have lower rates of severe

  Read More»

Our Latest Article

Long Form Lectures: A Lost Art? 
Posted on Aug 08, 2017

Article

Over on LinkedIn, we posted an article on long form lectures/presentations.

In that article, we take a look at a few video examples of excellent presentations made without the use of complex slides, technology, or jargon.

There are lessons to be learned from these presentations masters…lessons which we believe can make a big difference in our collective ability to communicate with prospective partners and customers.

 

 


Latest Posts

A Port Authority Model for the Life Sciences 
Posted on Jul 17, 2017

  Countless electrons have been spilled in the promotion of the biotech and life science industries in and around New York City. Indeed, tremendous strides have been made, especially when it comes to lab space and related infrastructure. Experienced pharma executives are available, making them ideal sources of management talent. Even the VCs are dipping

#BIO2017 – Dealmaking By Wandering Around 
Posted on Jul 10, 2017

According to Wikipedia, Management by Wandering Around (MBWA) is …refers to a style of business management which involves managers wandering around, in an unstructured manner, through the workplace(s), at random, to check with employees, equipment, or on the status of ongoing work. At Lacerta Bio, we’re not big fans of words such as “wandering” or

Thoughts Leading Up To #BIO2017 
Posted on Jun 15, 2017

  #BIO2017 is days away. What can we expect?   Crowded Partnering – By our unofficial count, the number of companies registered for One-on-One Partnering exceeds the number from San Francisco last year. While having more Exhibitors is nice, more people and companies in Partnering means more opportunities to in- or out-license, find new clients,

Google Plus   Facebook   Twitter
Powered By : Supra International Inc.